2000
March: Paracel acquired by Celera Genomics (deal worth $283M)
August: Oxford Molecular acquired by Pharmacopeia (deal worth $27M)
September: Neomorphic acquired by Affymetrix (deal worth $70M)
October: Empaheon acquired by eBioinformatics (deal worth $11M)
December: Proteome acquired by Incyte (deal worth $77M)
Â
2001
May: Rosetta Inpharmatics acquired by Merck (deal worth $620M)
July: Synomics acquired by Accelrys (deal worth $4M)
July: Momentum acquired by Cellomics
November: Genomica acquired by Exelixis (deal worth $110M)
Â
2002
January: NetGenics acquired by Lion Bioscience (deal worth $17M)
February: ProteoMetrics closes, software acquired by Genomic Solutions (value not disclosed)
March: Entigen ceases operations
March: DoubleTwist closes
December: InforMax acquired by Invitrogen (deal worth $42M)
Â
2003
January: Structural Genomics, GeneFormatics plan merger
February: Viaken Systems closes
February: Phase-it acquired by Europroteome (value not disclosed)
March: Molecular Mining closes
April: Argentys (formerly Blackstone) acquired by TurboWorx (value not disclosed)
April: LabBook discontinues retail operations; Rescentris licenses technology
Â